MeVis Medical Solutions AG (XTER:M3V) EBIT : €4.93 Mil (TTM As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is MeVis Medical Solutions AG EBIT?

MeVis Medical Solutions AG's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2024 was €2.30 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was €4.93 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. MeVis Medical Solutions AG's annualized ROC % for the quarter that ended in Mar. 2024 was 24.11%. MeVis Medical Solutions AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 2,032.74%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. MeVis Medical Solutions AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 11.43%.

MeVis Medical Solutions AG EBIT Historical Data

The historical data trend for MeVis Medical Solutions AG's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MeVis Medical Solutions AG EBIT Chart

MeVis Medical Solutions AG Annual Data

Trend

Dec13

Dec14

Dec15

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

EBIT

Get a 7-Day Free Trial

8.17

5.81

4.64

7.88

5.08

MeVis Medical Solutions AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
EBIT	Get a 7-Day Free Trial															3.46	4.42	2.44	2.64	2.30

Competitive Comparison of MeVis Medical Solutions AG's EBIT

For the Health Information Services subindustry, MeVis Medical Solutions AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MeVis Medical Solutions AG's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MeVis Medical Solutions AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where MeVis Medical Solutions AG's EV-to-EBIT falls into.

MeVis Medical Solutions AG EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €4.93 Mil.

MeVis Medical Solutions AG (XTER:M3V) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

MeVis Medical Solutions AG's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	4.594 * ( 1 - 2.71% )	/	( (18.343	+	18.734)	/ 2 )
=	4.4695026	/	18.5385
=	24.11 %

where

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	28.054	-	5.189	-	( 7.744	-	max(0, 6.849	-	11.371	+	7.744	))
=	18.343

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	25.131	-	2.715	-	( 4.872	-	max(0, 4.618	-	8.3	+	4.872	))
=	18.734

Note: The Operating Income data used here is two times the semi-annual (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

MeVis Medical Solutions AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	4.594	/	( ( (0.146 + max(-3.883, 0))	+	(0.306 + max(-1.998, 0)) )	/	2 )
=	4.594	/	( ( 0.146	+	0.306 )	/	2 )
=	4.594	/	0.226
=	2,032.74 %

where Working Capital is:

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(2.652	+	0	+	0.314)	-	(5.189	+	0	+	1.66)
=	-3.883

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(2.355	+	0	+	0.265)	-	(2.715	+	0	+	1.903)
=	-1.998

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

MeVis Medical Solutions AG's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	4.934	/	43.176
	=	11.43 %

MeVis Medical Solutions AG EBIT Related Terms

Thank you for viewing the detailed overview of MeVis Medical Solutions AG's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

MeVis Medical Solutions AG (XTER:M3V) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MeVis Medical Solutions AG (XTER:M3V) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

M3V:Germany M3V:Germany

Address

Caroline-Herschel-Strasse 1, Bremen, DEU, 28359

Website

http://www.mevis.de

MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.

MeVis Medical Solutions AG (XTER:M3V) Headlines

No Headlines